University of Rochester Medical Center
Obstetrics and Gynecology residency · Rochester, NY · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is University of Rochester Medicine's research in obstetrics and gynecology, which the program shares with other departments and affiliated hospitals.
About University of Rochester Medicineinstitution-wide obstetrics and gynecology research
Obstetrics and Gynecology publications from University of Rochester Medicine and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
38
works per year
35th of 81 obstetrics and gynecology residency programs
+2.7%
2-year growth
38th of 80 obstetrics and gynecology residency programs
21.2%
in top 10% of field (works before 2025)
44th of 67 obstetrics and gynecology residency programs
41.5%
cited above world average
42nd of 67 obstetrics and gynecology residency programs
Works per year · * 2026 so far
Obstetrics and Gynecology · 115Reproductive Medicine · 71
Obstetrics and Gynecology research topics at University of Rochester Medicine
Papers in the window; each links to the list on OpenAlex.
- Endometrial and Cervical Cancer Treatments 40
- Ovarian function and disorders 28
- Pregnancy and preeclampsia studies 23
- Gestational Diabetes Research and Management 21
- Ovarian cancer diagnosis and treatment 18
- Reproductive Health and Technologies 11
- COVID-19 Impact on Reproduction 10
- Maternal and Perinatal Health Interventions 7
Most cited at University of Rochester Medicine since 2024
All obstetrics and gynecology papers there on OpenAlex
- Polycystic ovary syndromeElisabet Stener‐Victorin et al. · Nature Reviews Disease Primers · 2024 · PubMed · cited 540
- Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trialRamez Nassef Eskander et al. · Nature Medicine · 2025 · PubMed · cited 93
- First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III TrialChristian Marth et al. · Journal of Clinical Oncology · 2024 · PubMed · cited 76
- Management of polycystic ovary syndrome must include assessment and treatment of mental health symptomsSnigdha Alur-Gupta et al. · Fertility and Sterility · 2024 · PubMed · cited 53
- Continuous glucose monitoring in pregnancies with type 1 diabetes: small increases in time-in-range improve maternal and perinatal outcomesNasim C. Sobhani et al. · American Journal of Obstetrics and Gynecology · 2024 · PubMed · cited 28
- Placental chronic inflammatory histopathology and fetal growth in a cohort with universal placental examinationCarolyn M. Salafia et al. · Placenta · 2024 · PubMed · cited 16
- Polycystic ovary syndrome: A review of diagnosis and management, with special focus on atherosclerotic cardiovascular disease preventionMerle L. Myerson et al. · Journal of clinical lipidology · 2024 · PubMed · cited 14
- The Ovarian-Adnexal Reporting and Data System (O-RADS) US Score Effect on Surgical Resection RateLuyao Shen et al. · Radiology · 2024 · PubMed · cited 11
- Association of polycystic ovary syndrome with atherosclerotic cardiovascular disease eventsIris TIENLYNN. Lee et al. · Fertility and Sterility · 2025 · PubMed · cited 10
- #88 Lenvatinib plus pembrolizumab versus chemotherapy as first-line therapy for advanced or recurrent endometrial cancer: primary results of the phase 3 ENGOT-en9/LEAP-001 studyChristian Marth et al. · International Journal of Gynecological Cancer · 2024 · cited 10